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Abstract. 
 
In previous work, we used a permeabilized cell
assay that reconstitutes nuclear export of protein kinase
inhibitor (PKI) to show that cytosol contains an export ac-
tivity that is distinct from Crm1 (Holaska, J.M., and B.M.
 
Paschal. 1995. 
 
Proc. Natl. Acad. Sci. USA.
 
 95: 14739–
14744). Here, we describe the puriﬁcation and character-
ization of the activity as calreticulin (CRT), a protein pre-
viously ascribed to functions in the lumen of the ER. We
show that cells contain both ER and cytosolic pools of
CRT. The mechanism of CRT-dependent export of PKI
requires a functional nuclear export signal (NES) in PKI
and involves formation of an export complex that contains
RanGTP. Previous studies linking CRT to downregulation
of steroid hormone receptor function led us to examine its
potential role in nuclear export of the glucocorticoid re-
ceptor (GR). We found that CRT mediates nuclear export
of GR in permeabilized cell, microinjection, and transfec-
tion assays. GR export is insensitive to the Crm1 inhibitor
leptomycin B in vivo, and it does not rely on a leucine-rich
NES. Rather, GR export is facilitated by its DNA-binding
domain, which is shown to function as an NES when
transplanted to a green ﬂuorescent protein reporter. CRT
deﬁnes a new export pathway that may regulate the tran-
scriptional activity of steroid hormone receptors.
Key words: nucleocytoplasmic transport • Ran GTP-
ase • nuclear pore complex • protein export • hormone
receptor
 
Introduction
 
Transport between the nuclear and cytoplasmic compart-
 
ments occurs through nuclear pore complexes (NPCs),
 
1
 
 elab-
orate channels that perforate the double membrane system
of the nuclear envelope. The large size (125 mD), complex
composition (
 
.
 
100 polypeptides), and architectural design of
NPCs relates to the central role of these structures in both
diffusion-based transport of small molecules and facilitated
transport of macromolecules (Doye and Hurt, 1997; Ohno et
al., 1998). The facilitated transport pathways are initiated
through the binding of soluble receptors to protein or ribonu-
cleoprotein (RNP) cargo endowed with either nuclear local-
ization signals (NLSs) or nuclear export signals (NESs). The
receptor–cargo complex then undergoes a series of physical
interactions with the NPC that culminate in the delivery of
cargo to the appropriate compartment (Görlich and Kutay,
1999; Nakielny and Dreyfuss, 1999).
In the past five years, there has been substantial progress
in characterizing the nuclear transport receptors and ana-
lyzing how their interactions with cargo are regulated. The
nuclear transport receptors described to date comprise a
 
superfamily of proteins sharing 
 
z
 
20% amino acid identity,
usually referred to as 
 
b
 
-importins or 
 
b
 
-karyopherins in
vertebrates and Kaps in yeast (Görlich et al., 1997). For ex-
ample, the budding yeast 
 
Saccharomyces cerevisiae
 
 en-
codes a total of fourteen 
 
b
 
-importin superfamily members,
many of whose transport functions have been character-
ized at the molecular level. Nine are import receptors, in-
cluding the 
 
b
 
-importin family member Kap95p, a receptor
that requires the adapter Kap60p to specify the cargo-
binding function of the complex. Adapter proteins are
used extensively in higher eukaryotes to mediate cargo
binding to 
 
b
 
-importin. The adapters identified in verte-
brates include 
 
a
 
-importin, snurportin, XRIP
 
a
 
, importin7,
and RanBP8 (Görlich and Kutay, 1999). Notably, five dis-
 
tinct 
 
a
 
-importins are expressed in human cells, several
of which preferentially bind to certain NLS substrates
(Kohler et al., 1999). Thus, adapters provide a form of
combinatorial flexibility that allows a variety of NLS-con-
taining cargo to be imported via a single 
 
b
 
-importin.
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The four export receptors identified thus far are expor-
tin-t, Msn5p, CAS, and Crm1. Exportin-t (Los1p in 
 
S. cere-
visiae
 
) is the export receptor for tRNA (Arts et al., 1998a;
Kutay et al., 1998). Msn5p is the export receptor for sev-
eral transcription factors in yeast, including the phosphor-
ylated form of Pho4p (Kaffman et al., 1998). CAS (Cse1p
in 
 
S. cerevisiae
 
) is a dedicated export receptor for 
 
a
 
-impor-
tin, emphasizing the critical nature of recycling pathways
for transport factors (Kutay et al., 1997; Hood and Silver,
1998). Crm1 (Xpo1p in 
 
S. cerevisiae
 
) is the nuclear export
receptor that has attracted the most attention because it
mediates export of proteins that contain the leucine-rich
NES, which was originally characterized in Rev and pro-
tein kinase inhibitor (PKI) (Fischer et al., 1995; Wen et al.,
1995; Fornerod et al., 1997; Stade et al., 1997). These re-
sults, together with functional identification of the leucine-
rich NES in diverse proteins, has led to the view that Crm1
is a general receptor for nuclear protein export.
Crm1 also functions as an export receptor for RNA.
Crm1 mediates nuclear export of partially spliced and un-
spliced transcripts encoded by HIV-1 (Cullen, 2000), and it
mediates nuclear export of certain uridine-rich snRNAs
(Ohno et al., 2000; Ossareh-Nazari et al., 2000). In both
cases, Crm1-dependent export requires one or more NES-
containing adapter proteins that bridge its interaction with
RNA cargo. Rev fulfills its adapter function through direct
binding to a structured element within the RNA transcript.
The adapters involved in Crm1-dependent export of uri-
dine-rich snRNAs include several proteins that assemble
into a cap-binding complex on these RNPs (Izaurralde et
al., 1995). Crm1 has also been implicated in bulk mRNA
export (Stade et al., 1997), however, this issue is controver-
sial (Neville and Rosbash, 1999). Indeed, establishing the
identity of export receptors directly responsible for mRNA
transport remains an area of active investigation. The best
candidates for mRNA export receptors include TAP/
Mex67p, Gle1p/Rss1p, Gle2p/Rae1p, and Dbp5p/Rat8p
(Murphy et al., 1996; Murphy and Wente, 1996; Gruter et
al., 1998; Braun et al., 1999; Hodge et al., 1999; Pritchard et
al., 1999). It is noteworthy that aside from Crm1, none of
the putative mRNA export receptors are related to the
 
b
 
-importin superfamily at the sequence level. This can be
interpreted as evidence for the existence of 
 
b
 
-importin–
independent pathways for transport through the NPC.
The export function of Crm1 requires participation of
the Ran GTPase. In the nucleus, direct binding of
RanGTP to Crm1 stabilizes the association of the receptor
with NES cargo (Görlich et al., 1997; Askjaer et al., 1998);
the resulting trimeric export complex can then undergo
translocation through the NPC. When the export complex
reaches the cytoplasmic side of the NPC, RanGAP-cata-
lyzed hydrolysis of RanGTP to RanGDP is thought to
trigger disassembly of the complex as part of the terminal
step of the pathway (Askjaer et al., 1999; Kehlenbach et
al., 1999). Crm1 and RanGDP are then reimported for the
next round of export. The RanGTP-dependent formation
of a trimeric complex in the nucleoplasm, and the disas-
sembly of the complex by RanGAP in the cytoplasm, are
reactions that are predicted to occur with the export re-
ceptors exportin-t, Msn5p, as well as CAS.
We recently developed a permeabilized cell assay that re-
constitutes nuclear export of PKI in a cytosol-dependent
manner, and showed that purified Crm1 and Ran are suffi-
 
cient to drive nuclear export in this system (Holaska and Pas-
chal, 1998). In the course of these studies, we made the sur-
prising observation that cytosol depleted of Crm1 still
supports nuclear export of PKI. Since this implies that cytosol
contains factors that can functionally substitute for Crm1 in
our assay system, we hypothesized that additional export re-
ceptors are present in mammalian cells (Holaska and Pas-
chal, 1998). Here, we describe the purification and character-
ization of a cytosolic factor that can mediate nuclear export
of PKI by a pathway that operates independent of Crm1. The
cytosolic factor is calreticulin (CRT), a calcium-binding pro-
tein implicated in protein folding in the ER lumen (Krause
and Michalak, 1997). However, we found that cells contain
both ER and cytosolic pools of CRT. We also demonstrated
that CRT-dependent export is fundamentally similar to
Crm1-dependent export, as both pathways involve formation
of trimeric complexes with NES substrate and RanGTP. One
striking difference between these pathways is that CRT, but
not Crm1, mediates nuclear export of the glucocorticoid re-
ceptor (GR). CRT interacts with the DNA-binding domain
(DBD) of GR, which we show is functional as an NES. These
protein–protein interactions underlie a nuclear export–based
mechanism for antagonizing the transcriptional activation
potential of GR, and may represent an important regulatory
step for other nuclear receptors as well.
 
Materials and Methods
 
Purification of the Cytosolic Export Activity
 
The export receptor (CRT) was purified from HeLa cell cytosol using PKI
export as the assay during all fractionation steps (Holaska and Paschal,
1998). Cytosol (20 ml, at a concentration of 10 mg/ml) was mixed end over
end with phenyl-Sepharose beads at a final ratio of 3:1 (vol cytosol/vol
beads) for 15 min at 4
 
8
 
C to deplete Crm1. A 55–70% ammonium sulfate
precipitation of the Crm1-depleted cytosol was collected by centrifugation
and resuspended in transport buffer (TB: 20 mM Hepes, pH 7.4, 110 mM
potassium acetate, 2 mM magnesium acetate, 1 mM EGTA) containing 2
mM DTT and a protease inhibitor cocktail. The resuspended material was
then diluted with saturated ammonium sulfate to a final concentration of
40%, clarified by centrifugation (40,000 
 
g
 
 for 30 min), and bound to phe-
nyl-Sepharose beads. A step gradient of decreasing ionic strength was
used for batch elution of the beads, resulting in recovery of the export ac-
tivity in 20% ammonium sulfate. The eluate was chromatographed on a
Superose 6 column (24-ml bed volume) at a flow rate of 0.25 ml/min in 2
 
3
 
TB. The active fractions were pooled, diluted to 5 ml with 50 mM Tris-
HCl buffer, pH 8.0, and chromatographed on a MonoQ column (1-ml bed
volume) using a linear gradient of 0–1 M NaCl for elution. The export ac-
tivity that eluted at 
 
z
 
350–500 mM NaCl corresponded to an 
 
z
 
60-kD
polypeptide by SDS-PAGE. Mass spectrometry performed on tryptic
fragments derived from the 60-kD band revealed the mass and sequence
of 11 different peptides contained within the sequence of human CRT (se-
quence data available from GenBank/EMBL/DDBJ under accession no.
A37057). The peptides and the corresponding residues in human CRT are
EQFLDGDAWTNR (25–36), HKSDFGK (42–48), FYGDQEKDK (56–
64), DKGLQTSQDAR (63–73), FYALSAR (74–80), HEQNID-
CGGGYVK (99–111), KVHVIFNYK (143–151), IKDPDAAKPED-
WDER (208–222), GEWKPR (273–278), QIDNPDYK (279–286), and
KDQDEEQR (359–366).
 
PKI Export Assay
 
The PKI export assay was performed in suspension-culture HeLa cells
(Holaska and Paschal, 1998). The assay involves nuclear loading of fluores-
cently labeled streptavidin–NLS (FITC–STV–NLS), addition of biotin-
ylated PKI (bPKI), and cytosolic factor–dependent export of the bPKI/
FITC–STV–NLS complex. The readout is the reduction of nuclear fluores-
cence that results from export stimulated by the addition of fractionated
cytosol or recombinant proteins. For quantitation of nuclear export, images
of nuclei (
 
z
 
50) were selected in the DAPI (4
 
9
 
6-diamidino-2-phenylindole) 
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channel and captured in the FITC channel using a Nikon Microphot-SA
microscope (40
 
3
 
 objective, NA 
 
5
 
 0.95) equipped with a Hamamatsu
C-4742-95 CCD camera. Image acquisition and analysis was carried out us-
ing Openlab 2.06 software, and data figures were constructed using Adobe
Photoshop
 
®
 
 5.02 and FreeHand 8.0. The error bars in each figure represent
the SD of mean nuclear fluorescence within the sample. The concentra-
tions of recombinant proteins used in individual PKI export experiments
are stated in the figure legends. Full-length CRT fused to glutathione-
 
S
 
-transferase (GST) was generally used at a concentration of 50 
 
m
 
g/ml. We
also expressed and characterized a GST–CRT fusion protein lacking the
first 17 amino acids that comprise the ER signal sequence. The activity of
recombinant CRT lacking the signal sequence was indistinguishable from
full-length CRT in our assays. Recombinant Ran was not routinely added
to permeabilized cell assays. The level of Ran that remains associated with
permeabilized cells is apparently sufficient for CRT-dependent export.
However, Ran does become rate-limiting at low concentrations of CRT,
which was the basis for Fig. 3 C. Human Crm1 used in the PKI export assay
was purified from HeLa cytosol by column chromatography. The effect of
leptomycin B (LMB) on PKI export in permeabilized cells was examined
by incubating the soluble factors with the compound (500 nM) for 15 min at
room temperature before performing the export reactions.
 
GR–GFP and RevM10–DBD–GFP Export Assays
 
A plasmid encoding rat GR fused to green fluorescent protein (GR–GFP)
was transfected into BHK cells grown on glass coverslips, using the cal-
cium phosphate method. In certain experiments, a plasmid encoding
CCAAT/enhancer-binding protein
 
 a 
 
fused to blue fluorescent protein (C/
EBP
 
a
 
–BFP) was included as a transfection marker. After transfection,
the cells were maintained in culture for 48 h, and then treated with 1 
 
m
 
M
agonist (corticosteroid or dexamethasone) to induce nuclear accumula-
tion of GR–GFP. The coverslips were washed, permeabilized with digito-
nin, and used in export assays. We assayed whether the DBD of the GR is
involved in its CRT-dependent export by testing whether a segment
within the domain can competitively inhibit transport on this path-
way. GST–CRT was preincubated with wild-type (WT) GR peptide
(CGGGKVFFKRAVEGQHNLY) and mutant GR peptide (CGG-
GKVAAKRAVEGQHNLY) for 15 min on ice. The GST–CRT/GR pep-
tide mixture was combined with permeabilized cells expressing GR–GFP,
and the effect on export was examined by fluorescence microscopy. Nu-
clear export of GR–GFP in vivo was studied by first inducing its nuclear
import with corticosteroid; the cells were then washed six times with cul-
ture medium containing charcoal-stripped serum. The cells were incu-
bated in the same medium in the absence and presence of 200 nM LMB,
and images were recorded by fluorescence microscopy over a 26-h time
course. 
 
crt
 
2
 
/
 
2
 
 and 
 
crt
 
1
 
/
 
1
 
 cell lines were derived from mouse embryo fibro-
blasts and immortalized by SV40 large T antigen.
Plasmids encoding either RevM10–GFP (derived from pXM10) (Love et
al., 1998), DBD–RevM10–GFP, or DBDmut–RevM10–DBD were con-
structed in pCDNA3, and used to transfect BHK cells grown on glass cover-
slips. 48 h after transfection, the GFP fusion proteins were induced to accu-
mulate in the nucleus with 1 
 
m
 
M dexamethasone for 1 h. The coverslips were
then placed into culture medium containing charcoal-stripped serum, and ex-
amined by fluorescence microscopy at 3 h intervals to score nuclear export.
 
Plasmids and Recombinant Proteins
 
The open reading frame of mouse CRT (sequence data available from Gen-
Bank/EMBL/DDBJ under accession no. AA243918) was amplified by PCR
using the oligonucleotide primers 5
 
9
 
-GGCTCGAGATGCTCCTTTCGGT-
GCCGCTC-3
 
9
 
 and 5
 
9
 
-CCCCTCGAGCTACAGCTCATCCTTGGCTTG-
3
 
9
 
 and cloned into the XhoI site of pGEX4T3. The GST–CRT fusion protein
was expressed by induction with IPTG and purified on glutathione-Sepharose
resin by established methods. Nucleotide-binding mutants of Ran (T24N and
G19V) were also expressed as GST fusions, using plasmids provided by Dr.
Ian Macara (University of Virginia, Charlottesville, VA) (Carey et al., 1996).
His-tagged Ran, expressed from a plasmid provided by Dr. Dirk Görlich
(University of Heidelburg, Heidelburg, Germany), was purified by sequential
metal chelation and gel filtration chromatography. FITC–STV–NLS, WT,
and NES-mutant forms of PKI were expressed and purified, as described pre-
viously (Holaska and Paschal, 1998). All protein stocks were prepared as sin-
gle-use aliquots, frozen in liquid nitrogen, and stored at 
 
2
 
70
 
8
 
C.
 
Export Complex Assembly Reactions
 
The affinity of CRT for the NES of PKI in the absence and presence of
RanGTP was measured using the Fisons Biosensor (Fisons). All manipu-
 
lations were carried out at ambient temperature. The NES surface was as-
sembled by first adding 50 
 
m
 
l neutravidin (1 mg/ml in PBS) (Pierce Chem-
ical Co.) to cuvettes precoated with biotin for 15 min. After washing with
PBS, 100 
 
m
 
l biotin-modified forms of WT NES peptide (bGSNDLA-
LKLAGLDINKTGGC) or mutant NES peptide (bGSNDLALKAAGA-
DINKTGGC) (each 0.5 mg/ml) was then added to the cuvette and incu-
bated for 15 min. After washing with PBS, the cuvette was used for
binding analysis. Recombinant GST–CRT, GST, and Ran (preloaded with
GMP-PNP) were used alone or in combination, the concentrations of
which are stated in the legend. The increase in refractive index was re-
corded as a function of time to measure association rate, and after a wash
step, the decrease in refractive index was recorded as a function of time to
measure dissociation rate. The FASTfit program (Fisons) was used to cal-
culate the 
 
k
 
a
 
, 
 
k
 
d
 
, and 
 
k
 
D
 
 using the relationship 
 
k
 
D 
 
5
 
 
 
k
 
d
 
/
 
k
 
a
 
. A complete de-
scription of the methods used with the Fisons biosensor have been pub-
lished (Rubio et al., 1997). The solid-phase assay used to measure
RanGTP incorporation into CRT and Crm1 complexes was performed es-
sentially as described previously (Black et al., 1999).
 
Subcellular Fractionation of CRT
 
Digitonin treatment of HeLa cells was carried out under conditions that
selectively permeabilize only the plasma membrane, resulting in the re-
lease of cytosolic proteins. Suspension-culture HeLa cells (10
 
9
 
) were col-
lected by centrifugation, washed in TB, diluted to 5 
 
3
 
 10
 
6
 
 cells/ml in TB,
and treated with 0.005% digitonin for 5 min on ice. These cells were then
diluted to 2 
 
3
 
 10
 
6
 
 cells/ml with TB, collected by centrifugation, and the su-
pernatant and pellet were recovered. Cell equivalents of intact cells, digi-
tonin-permeabilized cells, and the digitonin-released fraction were ana-
lyzed by SDS-PAGE and immunoblotting using primary antibodies to
CRT, Grp94, ERp72, Hsp70, PDI (all from StressGen), Crm1 (Holaska
and Paschal, 1998), NTF2 (Steggerda et al., 2000), and peroxidase-labeled
secondary antibodies (Pierce Chemical Co.), and detected by enhanced
chemiluminescence. The relative amounts of CRT and marker proteins in
the whole cell, permeabilized cell, and released fractions were determined
by scanning densitometry of films using ImageQuaNT 4.2. For subcellular
fractionation, 10
 
9
 
 suspension HeLa cells were mechanically lysed in 0.25 M
sucrose using a 21-gauge needle attached to a 10-ml syringe. The lysate
was clarified twice at 1,000 
 
g
 
, and the postnuclear supernatant was frac-
tionated by ultracentrifugation over 0.5 M sucrose at 160,000 
 
g
 
 for 2 h.
Gradient fractions were recovered from the bottom of the tube and ana-
lyzed by SDS-PAGE and immunoblotting.
 
Microinjection Analysis
 
BHK cells grown on gridded coverslips were microinjected using fem-
totips mounted on a Micromanipulator and Transjector (Eppendorf). We
addressed whether the sequence from the DNA-binding domain of the
GR can function as an NES using fluorescent conjugates of the WT and
mutant GR peptides used in the competition experiment (see above). The
peptides were coupled to FITC-labeled BSA using the heterobifunctional
cross-linker sulfo-SMCC (Pierce Chemical Co.) essentially as described
for preparation of FITC–BSA–NLS conjugates (Paschal and Gerace,
1995). Each GR peptide conjugate (1 mg/ml) was coinjected with
rhodamine-dextran (0.5 mg/ml) into the nuclei of BHK cells and incu-
bated for 30 min at 37
 
8
 
C. The cells were then processed for fluorescence
microscopy. The ability of cytosolic CRT to stimulate nuclear export of
the GR in vivo was examined using a microinjection assay. Transfected
BHK cells were treated with 1 
 
m
 
M dexamethasone to induce nuclear accu-
mulation of GR–GFP. GST–CRT (0.5 mg/ml) or GST (0.5 mg/ml) was
coinjected with rhodamine-dextran (0.5 mg/ml) into the cytoplasm of
BHK cells and incubated for 45 min at 37
 
8
 
C. The cells were then pro-
cessed for fluorescence microscopy.
 
Results
 
Purification of a Protein That Mediates PKI Export
 
In a previous study, we described a permeabilized cell assay
that reconstitutes nuclear export of bPKI complexed with
fluorescent STV (Holaska and Paschal, 1998). Nuclear ex-
port in this system requires a functional NES within PKI
and its recognition by one or more factors present in HeLa
cell cytosol. We also found that cytosol depleted of Crm1, 
The Journal of Cell Biology, Volume 152, 2001 130
 
or treated with 
 
N
 
-ethylmaleimide to inactivate Crm1, pro-
moted nuclear export of PKI to nearly the same extent as
control cytosol (Holaska and Paschal, 1998). Moreover, we
found that cytosol depleted of Crm1 was insensitive to
LMB, a potent inhibitor of Crm1 (Holaska, J.M., and B.M.
Paschal, unpublished observations). These observations
suggested that cytosol contains an export factor, biochemi-
cally distinct from Crm1, that recognizes the NES within
PKI and mediates its export from the nucleus.
We used the PKI export assay and cytosol depleted of
Crm1 (Holaska and Paschal, 1998) for purification of the ex-
port factor. We found that the export factor could be recov-
ered in a 55–70% ammonium sulfate precipitation, which
provided significant enrichment since most cytosolic proteins
were precipitated with 55% ammonium sulfate (data not
shown). We ultimately designed a purification scheme that
involved ammonium sulfate precipitation followed by chro-
matography on hydrophobic interaction, gel filtration, and
ion-exchange resins (see Materials and Methods). The final
step of the purification involved binding the export factor to a
MonoQ column and eluting with a linear salt gradient. We
observed that maximal PKI export activity eluted from the
MonoQ column at a salt concentration of 
 
z
 
400 mM NaCl,
corresponding to fractions 44 and 45 in the chromatographic
profile (Fig. 1 B). The same fractions were analyzed by gel
electrophoresis and silver staining and found to contain an
 
z
 
60-kD polypeptide (Fig. 1 A). Since the relative abundance
of the 60-kD polypeptide in fractions 44 and 45 correlates
with the levels of PKI export activity promoted by these frac-
tions, we conclude that it represents the export factor.
We examined whether the 60-kD export factor mediates
nuclear export of Rev, which, like PKI, contains a hydro-
phobic NES. A cell line expressing a Rev–GFP fusion pro-
tein (Love et al., 1998) was permeabilized with digitonin
and incubated with either buffer or the 60-kD factor. Nu-
clear export of Rev–GFP was observed in the presence of
the 60-kD factor (Fig. 1 C), and was blocked in the presence
of wheat germ agglutinin (data not shown), the latter exper-
iment confirming that export occurs through the NPC.
 
The 60-kD Nuclear Export Factor Is Cytosolic CRT
 
To determine the molecular identity of the 60-kD export
factor, we used the purified protein to generate tryptic
peptides, and analyzed their composition by mass spec-
trometry. The predicted masses of 11 different peptides
(see Materials and Methods) containing a total of 116
amino acids allowed us to identify the 60-kD factor as
CRT, an abundant calcium-binding protein. CRT is in-
volved in calcium homeostasis, and it is also thought to in-
teract transiently with partially folded proteins as part of a
quality control mechanism that operates in the lumen of
the ER (Krause and Michalak, 1997). However, several
laboratories have reported that CRT may reside in the nu-
cleus and cytoplasm (Jethmalani et al., 1997; Roderick et
 
polypeptide. Mass spectrometry of tryptic fragments from the 60-
kD factor revealed its identity as CRT. (C) The 60-kD factor
(CRT) mediates nuclear export of Rev. A cell line expressing Rev–
GFP (Love et al., 1998) was grown on coverslips, permeabilized
with digitonin, and incubated with buffer or purified CRT. Nuclear
export, as visualized in the fluorescence microscope, was observed
in samples incubated with CRT, but not with buffer alone.
 
Figure 1.
 
Identification of a 60-kD export factor as CRT. (A and
B) Purification of the export activity. Crm1-depleted cytosol was
fractionated by ammonium sulfate precipitation, hydrophobic in-
teraction, gel filtration, and MonoQ chromatography. Each frac-
tion was tested for activity in the PKI export assay (Holaska and
Paschal, 1998). The final step of the purification was MonoQ chro-
matography. The export activity profile is plotted as the decrease in
mean nuclear fluorescence, and the protein profile is shown by
SDS-PAGE (7% gel, silver-stained). The maximum export activity
in fractions 44 and 45 corresponds to the abundance of a 60-kD 
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al., 1997), suggesting that cells contain both ER lumenal
and cytosolic forms of the protein.
Since we purified CRT from a highly clarified (150,000 
 
g
 
)
extract free of membranous organelles, it seemed very likely
that the CRT identified in our purification scheme is a cyto-
solic protein. To demonstrate that cultured cells contain a cy-
tosolic form of CRT, we incubated HeLa cells with a concen-
tration of digitonin (0.005%) that selectively permeabilizes
Figure 2. HeLa cells contain both microsomal and cytosolic pools of CRT. (A and B) CRT is released from HeLa cells by digitonin permeabi-
lization. Suspension HeLa cells (whole cells) were permeabilized with digitonin, collected by centrifugation, and then the fractions were ana-
lyzed by immunoblotting. A pool of CRT, and most of the Hsp70, are released from cells (Released), whereas the ER lumenal proteins
Grp94, ERp72, and PDI are retained (Perm cells). The CRT released by digitonin permeabilization is susceptible to proteinase K digestion,
indicating it is not enclosed within membrane-bound vesicles. (C) CRT fractionates as both a microsomal and a cytosolic protein. A postnu-
clear supernatant from HeLa cells was fractionated over a sucrose gradient and analyzed by SDS PAGE and immunoblotting. CRT and the
ER markers Grp94, Erp72, and PDI partition with microsomes (fractions 2–4). CRT also partitions with the soluble proteins Crm1, Hsp70,
and NTF2 (fractions 12–14). (D) The CRT in the microsomal fraction is protected from protease digestion. Fraction 2 from the sucrose gradi-
ent was treated with proteinase K (80 mg/ml, 15 min at room temperature) in the absence and presence of detergent (1% Triton X-100); only
the latter condition resulted in digestion of CRT and the ER marker protein PDI. (E) The CRT in the soluble fraction is susceptible to pro-
tease digestion. Fraction 13 from the sucrose gradient was treated with proteinase K as above. CRT and the soluble marker Hsp70 were de-
graded in the absence of detergent. 
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Figure 3. CRT-dependent export of PKI in digitonin permeabilized cells. (A) Nuclear export of PKI can be reconstituted by re-
combinant CRT, and requires a functional NES within PKI. HeLa cell nuclei were loaded with fluorescently labeled STV–NLS
(FITC–STV–NLS), washed with buffer, and incubated with bPKI and soluble export factors. After the export reaction, cells were
washed, pipetted onto glass slides, and viewed by fluorescence microscopy. Nuclear export of PKI/FITC–STV–NLS, visualized as
the loss of nuclear fluorescence, was observed if the reaction was supplemented with HeLa cell–derived CRT (50 mg/ml) or re-
combinant GST–CRT (50 mg/ml). Nuclear export was not observed when the reaction was supplemented with GST (50 mg/ml), or
if the NES mutant of PKI (L41,44A; MUT PKI) was used instead of WT PKI, or if PKI was omitted from the assay. Cells were
stained with DAPI to show the location of the nuclei in each field. (B) Quantitation of the relative levels of nuclear export from
the experiments shown in A. The level of nuclear export promoted by the addition of HeLa cell cytosol is shown for comparison.
(C) CRT and Ran-dependent export of PKI. Export reactions were performed at a subsaturating concentration of CRT (5 mg/ml)
and the Ran mutants G19V and T24N (each at 10 mg/ml). Export was promoted by the Ran G19V mutant and inhibited by the
Ran T24N mutant. This indicates that CRT-dependent export requires the GTP form of Ran. 
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the plasma membrane, thereby releasing only cytosolic pro-
teins. Immunoblotting of pre- and postpermeabilization frac-
tions revealed that approximately one third of total cellular
CRT is released from cells by treatment with digitonin (Fig. 2
A). In contrast, the lumenal proteins Grp94, ERp72, and PDI
were retained within digitonin-permeabilized cells, confirm-
ing that the integrity of the ER was not compromised during
the experiment. The CRT released from cells by digitonin is
not contained within vesicles, based on the sensitivity of the
protein to proteinase K digestion (Fig. 2 B).
Figure 4. CRT forms a trimeric complex with the
leucine-rich NES and RanGTP. A synthetic peptide
containing the NES of PKI (WT or NES mutant)
was immobilized on the surface of the biosensor cu-
vette through a biotin–STV linkage. The binding re-
sponse of recombinant proteins to immobilized pep-
tide was measured as the increase in refractive index
as a function of time. (A) CRT binding to the WT
NES requires the presence of RanGTP. GST–CRT
(50 mg/ml) and Ran preloaded with GMP-PNP (50
mg/ml) were added alone, or in combination, to cu-
vettes containing immobilized WT NES or mutant
NES (L41,44A). The arrow indicates the time at
which buffer (PBS) was infused. Complex formation
is observed in the presence of a WT NES, CRT, and
RanGTP (red tracing). CRT and Ran do not form a
complex on a mutant NES (light blue tracing), and
only background levels of binding are observed if
CRT or Ran is omitted from the assay (dark blue
and green tracings, respectively). Note that the light
blue and green tracings overlap at z40 arc s, which
represents background binding. (B) Measurement
of the affinity of CRT for NES in the presence of
RanGTP. The association rate of CRT for NES in
the presence of Ran was measured over a concen-
tration range of CRT (1.12–22.4 nM). The dissocia-
tion rate was measured in a similar manner after in-
fusion of buffer (beginning at 400 s), and the
FASTfit program was used to calculate the affinity
of CRT for NES in the presence of Ran (KD 5 8.5
nM). (C) Measurement of the affinity of Crm1 for
NES in the presence of RanGTP. The methods de-
scribed above were used to measure the association
and dissociation rates of the trimeric complex, and
the FASTfit program was used to calculate the af-
finity (KD 5 11 nM). (D) RanGTP binding to CRT
and Crm1 is stimulated by the NES. His-tagged
CRT and Crm1 were adsorbed to microtiter wells,
and binding of Ran was measured in the absence
and presence of the WT and mutant NES peptides.
Since the recombinant Ran was preloaded with
GTP radiolabeled on the terminal phosphate, the
counts measured in the bound fraction specifically
reflect the triphosphate form of Ran. Including WT
NES in the binding reaction stabilizes the interac-
tion of RanGTP with both CRT and Crm1. 
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Figure 5. CRT-dependent nuclear export of the GR is mediated by its DBD. (A) BHK cells were cotransfected with plasmids encoding
C/EBPa–BFP and GR–GFP and grown for 48 h. The transfected cells were permeabilized with digitonin and export assays were per-
formed in the presence of buffer alone, GST (50 mg/ml), or GST–CRT (50 mg/ml). Export assays were also performed with GST–CRT
that was preincubated with a peptide (1 mg/ml) from within the DBD of the GR (WT GR peptide; residues 460–474:
CGGGKVFFKRAVEGQHNLY). The control was a mutant peptide with two amino acid changes (MUT GR peptide; residues 460–
474: CGGGKVAAKRAVEGQHNLY). CRT-dependent export of GR–GFP was blocked by preincubation with WT, but not mutant,
peptide. This suggests that CRT recognition of the GR involves the DNA recognition helix within the DBD. (B) The DBD of GR is a
functional NES. A plasmid encoding the NES mutant of Rev (RevM10) fused to the hormone-binding domain of GR and GFP was
used to assay nuclear export. The GFP fusion undergoes agonist-dependent nuclear import (1Dex), but fails to undergo nuclear export
because of the mutations (L78D,E79L) in the NES of Rev. Nuclear export is restored in a GFP fusion containing a WT DBD (DBDwt–
RevM10–GFP), but not in a GFP fusion containing a mutant DBD (DBDmut–RevM10–GFP). The DBD in these constructs corre-
sponds to residues 432–528 in human GR, and the mutations are F463,464A. (C) The DNA recognition helix in GR functions as an
NES. The peptides used in the competition experiment were coupled to fluorescently labeled BSA, and analyzed by nuclear microinjec-
tion and microscopy. The WT GR-peptide, but not the MUT GR-peptide, promotes nuclear export of the fluorescent conjugate to the
cytoplasm of BHK cells. 
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Additional evidence for cytosolic and ER forms of CRT
was obtained by subcellular fractionation. Postnuclear su-
pernatants from mechanically lysed HeLa cells were sub-
jected to ultracentrifugation on sucrose gradients, and the
fractions were collected and analyzed by immunoblotting.
CRT and the ER marker proteins Grp94, ERp72, and PDI
were detected in the microsomal fraction at the bottom of
the gradient (Fig. 2 C, lanes 2–4). CRT was also detected
in the cytosolic fraction at the top of the gradient, along
with the soluble proteins Crm1, Hsp70, and NTF2 (Fig. 2
C, lanes 12–14). We extended this analysis to show that the
CRT in the microsomal fraction is protected from protein-
ase K digestion, unless the membrane is solubilized by the
detergent Triton X-100 (Fig. 2 D). In contrast, the CRT in
the soluble fraction is susceptible to proteinase K diges-
tion, even in the absence of detergent. Our data provides
unequivocal evidence for two pools of CRT, the first con-
tained within the lumen of the ER, and the second con-
tained within cytosol.
 
The NES of PKI Is Required for
CRT-dependent Export
 
A logical interpretation of our results showing that cytoso-
lic CRT can stimulate nuclear export of PKI and Rev is
that it functions as a nuclear export receptor. One prop-
erty expected of a receptor is specific recognition of a sig-
nal within the macromolecule that undergoes nuclear ex-
port. For example, Crm1 can discriminate between a WT
NES and a transport-defective NES in proteins such as
Rev and PKI (Fischer et al., 1995; Wen et al., 1995), and
exportin-t can discriminate between mature and incom-
pletely processed tRNAs (Arts et al., 1998b). We ad-
dressed this issue by producing recombinant CRT, and ex-
amining whether it can discriminate between WT PKI that
is functional for export, and a mutant (MUT) PKI that is
nonfunctional for export (Wen et al., 1995). Using the per-
meabilized cell assay, we determined that GST–CRT (50
 
m
 
g/ml) stimulates export of WT PKI to the same extent as
CRT (50 
 
m
 
g/ml) purified from cells, confirming that CRT
itself is the active component from HeLa cytosol (Fig. 3, A
and B). However, GST–CRT does not stimulate export of
a mutant PKI containing the two well-characterized amino
acid substitutions (L41,44A) that inactivate the leucine-
rich NES (Wen et al., 1995). In addition, nuclear export
was not observed if PKI was omitted from the assay (Fig.
3, A and B). These results indicate that nuclear export me-
diated by CRT requires specific recognition of the NES
within PKI. Our results also suggest that CRT, like Crm1,
physically contacts hydrophobic amino acids within the
NES of its export substrate.
We obtained evidence that CRT shares a second prop-
erty with Crm1, namely, that its export function is regu-
lated by the Ran GTPase system. In permeabilized cell
assays containing a subsaturating concentration of GST–
CRT, nuclear export of PKI could be reconstituted in the
presence of WT Ran or a mutant Ran that mimics the
GTP-bound form (G19V) of the GTPase, but not by a mu-
tant Ran that mimics the nucleotide-free form (T24N) of
the GTPase (Fig. 3 C). Taken together, our data indicate
that CRT and Ran cooperate to mediate nuclear export of
PKI, and that this pathway involves CRT recognition of the
 
leucine-rich NES of PKI. These properties are consistent
with CRT functioning as a nuclear export receptor for PKI.
 
CRT Assembles into a Trimeric Complex Containing 
NES and RanGTP
The functional interactions between CRT, PKI, and Ran
measured in the permeabilized cell assay suggests these
proteins may assemble into a trimeric export complex. For
example, the export receptor Crm1 coassembles with
NES-containing cargo and the GTP-bound form of Ran in
vitro (Fornerod et al., 1997; Askjaer et al., 1998); this tri-
meric assembly of proteins is thought to represent the
complex that is actively exported from the nucleus (Gör-
lich and Kutay, 1999; Nakielny and Dreyfuss, 1999). Each
of the export receptors of the b-importin superfamily is
thought to assemble into trimeric complexes that contain
their respective cargo and RanGTP.
We examined whether CRT can discriminate between a
functional and mutant NES and the potential role of
RanGTP using a biosensor assay that measures molecular
interactions in real time. The principle involves monitoring
dynamic changes in refractive index that occur when a pro-
tein in solution binds to a ligand immobilized on the sensor
surface (Rubio et al., 1997). The ligand used for this analy-
sis corresponded to the NES of PKI, synthesized as a pep-
tide containing an NH2-terminal biotin. This facilitates ori-
entation-specific capture of the NES peptide onto the
neutravidin-coated surface of the sensor. Addition of re-
combinant CRT (50 mg/ml) to the surface containing the
WT NES resulted in a negligible change in refractive index
(Fig. 4 A, green tracing). Similarly, addition of recombi-
nant Ran (50 mg/ml, preloaded with GMP-PNP) to the WT
NES caused only a slight change in refractive index (dark
blue tracing), most of which was lost upon infusion of
buffer (arrow). In contrast to these results, simultaneous
addition of CRT (50 mg/ml) and Ran (50 mg/ml) to the WT
NES resulted in an increase in refractive index to z140 arc
s (red tracing), one third of which was retained upon buffer
infusion. Thus, CRT and Ran exhibit cooperative binding
to the NES. The binding of CRT and Ran in this reaction is
specific for a WT NES, since addition of these proteins to a
surface containing a mutant NES did not cause a detect-
able increase in refractive index (light blue tracing).
We measured the on-rates for cooperative CRT and
Ran binding to the WT NES over a 20-fold concentration
range of CRT (Fig. 4 B), and, from this, we calculated an
association rate constant ka 5 7.41 3 105 M 21 s 21. The
CRT/Ran/NES complex dissociated with a rate constant
kd 5 6.30 3 1023 s21. The ratio kd/ka reveals a KD 5 8.5
nM. As a positive control for this analysis, we performed
binding experiments using Crm1 purified from HeLa cells,
and confirmed that under our reaction conditions Crm1
and Ran bind cooperatively to the NES (Fig. 4 C). The as-
sociation and dissociation rate constants for the Crm1/
Ran/NES complex are ka 5 7.55 3 105 M21 s21 and kd 5
8.4 3 1023 s 21, respectively, revealing a KD 5 11 nM. In
summary, our data show that CRT, like Crm1, can selec-
tively bind to the leucine-rich NES through a high-affinity
interaction that requires the presence of RanGTP.
We used a complementary approach to verify that
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and NES peptides. Recombinant CRT was immobilized in
microtiter wells, and [g-32P]GTP-loaded Ran was added to
wells in the absence or presence of WT or mutant NES
peptides (500 nM each). As a positive control, recombi-
nant Crm1 was immobilized and tested in parallel. In this
assay, RanGTP binding to both CRT and Crm1 is stimu-
lated approximately fourfold in the presence of WT NES
peptide (Fig. 4 D). In contrast, RanGTP binding to both
CRT and Crm1 in the presence of mutant NES peptide
was similar to the level of binding in the absence of pep-
tide. Our results indicate that the NES is necessary for effi-
cient incorporation of RanGTP into the CRT export com-
plex. The assembly of RanGTP into export complexes
appears to be a conserved feature of both CRT- and
Crm1-dependent export pathways.
Nuclear Export of GR Is Mediated by Its DBD
Our finding that CRT can function as a nuclear export re-
ceptor for NES-containing proteins was intriguing in light
of reports that CRT may physically interact with nuclear
hormone receptors that are known to undergo nuclear im-
port and export. CRT was shown to block binding of the
glucocorticoid, androgen, and vitamin D receptors to their
respective DNA response elements in gel-shift assays
(Burns et al., 1994; Dedhar et al., 1994; Wheeler et al.,
1995). The interaction was proposed to involve the DNA
recognition helix situated between the two zinc fingers in
the DBD of the receptors. This was based on the observa-
tion that a DNA recognition helix peptide inhibits the
ability of CRT to block nuclear receptor binding to DNA,
presumably because the peptide acts as a competitive in-
hibitor for the binding reaction (Burns et al., 1994; Dedhar
et al., 1994; Wheeler et al., 1995). In addition, overexpres-
sion of CRT was shown to antagonize nuclear receptor-
dependent transcriptional activation. CRT could antago-
nize nuclear receptor-dependent transcriptional activation
by interfering with the association of the receptor with its
DNA response element, by mediating nuclear export of
the steroid receptor (see below), or through a combination
of interference- and export-based mechanisms.
We tested whether CRT can mediate nuclear export of
GR in a permeabilized cell assay. GR was expressed in
BHK cells as a GFP fusion protein (Carey et al., 1996), to-
gether with a BFP fusion of a nuclear protein (C/EBPa–
BFP). After inducing nuclear import of GR–GFP with
corticosteroid, the cells were washed, permeabilized with
digitonin, and incubated with the indicated proteins. Upon
addition of GST–CRT, the GR–GFP was exported from
the nucleus, whereas no export was observed upon addi-
Figure 6. LMB-insensitive nuclear export analyzed in vitro and
in vivo. (A) Nuclear export mediated by CRT is not inhibited by
LMB under conditions where Crm1-dependent export is inhib-
ited. PKI export was measured in digitonin-permeabilized cells
using recombinant CRT (25 mg/ml) and purified Crm1 (50 mg/
ml), pretreated with 500 nM LMB for 15 min at room tempera-
ture. The level of export promoted by HeLa cytosol is shown for
comparison. (B) Nuclear export of the GR is not inhibited by
LMB in living cells. BHK cells were transfected with full-length
GR fused to GFP (GR–GFP). After nuclear import of GR–GFP
was induced with 1 mM corticosteroid for 1 h, the cells were
washed extensively with medium containing charcoal-stripped se-
rum, and incubated at 378C in the absence or presence of 200 nM
LMB. At the indicated time points, coverslips were removed and
the localization of GR–GFP recorded by fluorescence micros-
copy. Nuclear export of GR–GFP from the nucleus to the cyto-
plasm is observed in 6 h, and nuclear export is unaffected by the
presence of LMB. Nuclear export mediated by Crm1 was
blocked at the 6-h time point, as measured by nuclear microinjec-
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tion of GST (Fig. 5 A). In all samples, C/EBPa–BFP re-
mained within the nucleus, demonstrating that the nuclear
envelope remained intact during the experiment.
To address whether the DBD of GR can function as an
NES, we designed a transfection-based assay that scores
the distribution of a GFP reporter protein by fluorescence
microscopy. The GFP reporter plasmid encodes an NES
mutant of Rev and the hormone-binding domain of GR;
the latter facilitates agonist-dependent nuclear import. Be-
cause of the mutation in the NES of Rev, the GFP re-
porter remains nuclear after agonist removal (Fig. 5 B)
(Love et al., 1998). We found that fusion of the DBD of
GR to the reporter restored its ability to undergo nuclear
export, evident at the 6-h time point. In contrast, muta-
tions (F463,464A) within the DNA recognition helix abol-
ished the ability of the DBD to mediate nuclear export of
the GFP reporter. These results identify the DBD of GR
as a new type of NES, and implicate the DNA recognition
helix as an integral part of the signal.
The capacity of the DNA recognition helix itself to func-
tion as an NES was analyzed by microinjection in cultured
cells. Peptides (GR residues 460–474) containing WT and
mutant (F463,464A) forms of the DNA recognition helix
were synthesized and coupled to FITC-labeled BSA. After
nuclear microinjection, the fluorescent conjugate contain-
ing the WT peptide (WT GR-peptide) was exported to the
cytoplasm, whereas the fluorescent conjugate containing
the mutant peptide (MUT GR-peptide) remained within
the nucleus (Fig. 5 C). In both cases, the rhodamine-
labeled dextran that was coinjected remained in the nu-
cleus, indicating that the nuclear envelope remained intact
during experimental manipulations. These data confirm
and extend our results obtained by transfection (Fig. 5 B),
showing that the DBD of GR is a functional NES.
Given our results showing that the DBD, and, more spe-
cifically, the DNA recognition helix, can function as an
NES, we predicted that a peptide from the DBD might act
as a competitive inhibitor for CRT-dependent export of
GR. We tested this in the permeabilized cell assay by ana-
lyzing nuclear export of GR–GFP in the presence of the
DNA recognition helix peptide. We found that CRT-
dependent nuclear export of GR was blocked in the pres-
ence of WT peptide (1WT GR Peptide), but not in the
presence of mutant peptide (1MUT GR peptide) contain-
ing two mutations that abrogate the export activity of the
intact DBD or the helix (Fig. 5 A). Taken together, our re-
sults clearly demonstrate that CRT mediates nuclear ex-
port of GR through an interaction with the DBD, and that
binding is specific for the DNA recognition helix.
LMB-insensitive Nuclear Protein Export In Vitro and 
In Vivo
LMB inhibits Crm1-dependent export pathways by modifi-
cation of a critical cysteine necessary for NES binding
(C529; Kudo et al., 1999). We examined whether CRT-
dependent nuclear export is inhibited by LMB in the PKI
assay, using Crm1 as a positive control. We found that the
export activity of CRT is not inhibited by LMB under con-
ditions where the compound blocks the activity of Crm1
(Fig. 6 A). This result, together with our data showing that
CRT can mediate nuclear export of GR in permeabilized
cells, led us to hypothesize that steroid receptor export
would be insensitive to LMB. We tested this by monitoring
nuclear export of GR–GFP in the absence and presence of
LMB over a 26-h time course. We observed no differences
in the apparent rate of GR–GFP nuclear export, or in the
extent of its cytoplasmic accumulation (Fig. 6 B). We con-
firmed that the Crm1-dependent export pathway was in-
hibited in cells taken at the 6-h time point. This involved
Figure 7. CRT mediates nuclear export of GR in vivo. (A) Cyto-
plasmic injection of recombinant CRT is sufficient to stimulate
nuclear export of GR. BHK cells expressing GR–GFP were in-
jected with GST–CRT or GST (0.5 mg/ml each), and the distribu-
tion of GR–GFP was examined by fluorescence microscopy after
a 45 min incubation at 378C. Uninjected cells are indicated with
arrows. (B) Immunoblot showing CRT and Crm1 expression in
immortalized mouse embryo fibroblasts derived from WT cells
(crt1/1), CRT knockout cells (crt2/2) (Mesaeli et al., 1999), and
CRT-knockout cells transfected with full-length CRT (crt2/2
[1CRT]). (C) Nuclear export of GR is impaired in the absence of
CRT, and is restored by CRT expression. A plasmid encoding
GR–GFP was transfected into the indicated cell lines, and nuclear
accumulation of the reporter was induced with dexamethasone
(1Dex). After agonist removal, the cells were examined at 3 h in-
tervals to monitor nuclear export. Nuclear export of the GR–GFP
reporter was observed in WT (crt1/1) and CRT-transfected (crt2/2
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showing that a fluorescent conjugate of PKI is retained
within nuclei after microinjection (data not shown). These
results provide compelling pharmacological evidence that
nuclear export of GR occurs independently of the Crm1
export pathway. Similar results have been obtained by im-
munofluorescence microscopy of the progesterone and
GRs (Tyagi et al., 1998; Liu and DeFranco, 2000). The
LMB insensitivity of CRT and its ability to stimulate nu-
clear export of GR in permeabilized cells implies that it
could mediate nuclear export of GR in living cells.
CRT Mediates Nuclear Export of GR In Vivo
The results of two experiments demonstrated that CRT
mediates nuclear export of GR in the cell. In the first ex-
periment, we injected GST–CRT into the cytoplasm of
cells expressing nuclear GR–GFP. After microinjection
into the cytoplasm, GST–CRT stimulated nuclear export
of GR–GFP, whereas GST had no effect (Fig. 7 A). The
rhodamine-dextran remained in the cytoplasmic compart-
ment, showing that the nuclear envelope of injected cells
remained intact. In the second experiment, we assayed nu-
clear export of GR–GFP in mouse embryo fibroblasts de-
rived from crt2/2 mice (Mesaeli et al., 1999). As controls,
we assayed nuclear export of GR–GFP in WT cells (crt1/1)
and in the knockout cells transfected with a plasmid en-
coding CRT (crt2/2[1CRT]). Immunoblotting of lysates
from these cell lines confirmed the expression of CRT in
WT (crt1/1) and transfected cells (crt2/2[1CRT]), and
that the expression of Crm1 was similar in all three cell
lines. (Fig. 7 B). GR–GFP was transfected into the cell
lines and induced to undergo nuclear import with dexa-
methasone. After removal of dexamethasone, the cells were
examined at 3-h time points to evaluate nuclear export of
GR–GFP. We found that GR–GFP export in crt1/1 cells
was visible at the 6-h time point and was virtually com-
plete by the 9-h time point. In contrast, GR–GFP was re-
stricted to the nucleus in the crt2/2 cells, indicating that the
reporter failed to undergo nuclear export. The crt2/2 cells
transfected with the CRT plasmid showed a slight en-
hancement of GR–GFP export at the 3-h time point, and
with nearly quantitative export at the 9-h time point.
These data demonstrate that CRT is necessary for nuclear
export of GR in vivo, and provide compelling support for
our hypothesis that CRT is the receptor for a distinct nu-
clear export pathway.
Discussion
Here, we have identified cytosolic CRT as a receptor for
nuclear protein export. The approach involved fraction-
ation of HeLa cell cytosol by column chromatography, and
analysis of these fractions using the PKI export assay (Ho-
laska and Paschal, 1998). An important element of our
strategy for identifying new export activities was the use of
cytosol that was incubated with phenyl-Sepharose, a pre-
treatment resulting in quantitative depletion of Crm1.
Since total PKI export activity in the pretreated cytosol is
reduced by z10% compared with neat cytosol (Holaska
and Paschal, 1998), it was logical to infer the presence of
additional rate-limiting export factors. Evidence that the
export factor would correspond to a receptor, as opposed
to a regulator, was obtained by showing its specific deple-
tion by an NES conjugate (Holaska and Paschal, 1998).
These biochemical criteria led us to suggest that mamma-
lian cells utilize at least one additional receptor for nuclear
transport of proteins with hydrophobic export signals, a
hypothesis that we have now validated with the purifica-
tion and characterization of CRT.
The primary structure of CRT is unrelated to the
b-importin superfamily of nuclear transport receptors, in-
cluding the export receptors Crm1, CAS, exportin-t, and
Msn5p. However, CRT does share important functional
properties with Crm1 that underlie its function as an ex-
port receptor. Both CRT and Crm1 bind directly to trans-
port substrates through interactions that involve bulky hy-
drophobic residues within the NES of PKI. The formation
of these export receptor–substrate complexes requires the
presence of RanGTP, indicating the assembly reaction is
cooperative (Fornerod et al., 1997; Askjaer et al., 1998)
and that it is likely to occur in the nucleoplasm (Richards
et al., 1997). Similar mechanisms could also be used to pro-
mote the disassembly of CRT and Crm1 export complexes.
In the case of Crm1, RanGAP-mediated hydrolysis of
RanGTP to RanGDP on the cytoplasmic side of the NPC
is important for disassembly of the Crm1 export complex
in the terminal step of export (Askjaer et al., 1999).
An important finding that emerged from our study is
that CRT and Crm1 have overlapping, but nonidentical,
specificity for export substrates. We purified CRT based
on its ability to mediate nuclear export of PKI, and we fur-
ther showed that it binds directly to the NES of PKI in the
presence of RanGTP with a KD 5 8.5 nM. In the same as-
say, we found that Crm1 binds to the NES of PKI in the
presence of RanGTP with a KD 5 11 nM. CRT was also
found to mediate nuclear export of Rev. Since PKI and
Rev are also exported by Crm1, these represent overlap-
ping export substrates for the two receptors. Point muta-
tions in the PKI NES that disrupt CRT binding also re-
duce Crm1 binding (Wen et al., 1995), indicating that
similar molecular determinants within the NES in PKI are
recognized by both export receptors.
Using two different receptors for the same export sub-
strates may provide redundancy for this essential process.
CRT could also define a more specialized protein export
pathway that is responsive to the physiological state of the
cell. Total CRT expression increases in response to heat
shock (Conway et al., 1995), an effect that has been inter-
preted with regard to its role in protein folding (Trom-
betta and Helenius, 1998). However, it is tempting to spec-
ulate that cellular stress may also increase the cytosolic
pool of CRT, which could mediate nuclear export of pro-
teins and RNAs that are important for the heat shock re-
sponse. CRT can bind to certain RNPs in vitro through
both protein and RNA contacts (Nakhasi et al., 1994;
Cheng et al., 1996). Though the significance of these inter-
actions is unknown, they may warrant an investigation of a
potential role for CRT in RNA export.
CRT was identified about 25 years ago as an abundant
calcium-binding protein of the ER (Ostwald and MacLen-
nan, 1974), and it has been ascribed two different, but po-
tentially overlapping, functions. The first function involves
calcium homeostasis, a logical role given the presence of
calcium-binding sites in the protein, and its ability to regu-
late the calcium ATPase SERCA2 through protein–pro-
tein interactions (Camacho and Lechleiter, 1995). The
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gomerization of glycoproteins (Vassilakos et al., 1998),
and protection of nonglycosylated proteins from thermal
denaturation (Saito et al., 1999). How these chaperone-
like properties of CRT may relate to its function as a nu-
clear export receptor is unknown, however, it should be
noted that CRT binding to export substrates is highly spe-
cific and displays nanomolar affinity in the presence of
RanGTP. This affinity is 400-fold greater than the affinity
of CRT for folding intermediates of hemagglutinin (Peter-
son and Helenius, 1999).
Cytosolic CRT could be regulated through intracellular
signaling pathways involving calcium binding or phos-
phorylation (Krause and Michalak, 1997). However, we note
that these modes of regulation do not appear to be neces-
sary for the export function of CRT in our assays based on
two observations. First, the permeabilized cell assays were
performed in the presence of EGTA, and supplementing
the buffer with excess calcium had no effect on the level of
PKI export stimulated by CRT (Holaska, J.M., and B.M.
Paschal, unpublished observations). Second, the coopera-
tive assembly of CRT, NES, and RanGTP was achieved
using recombinant proteins produced in Escherichia coli,
indicating that posttranslational modifications are not re-
quired for formation of the trimeric export complex. How-
ever, it remains possible that recombinant CRT undergoes
posttranslational modification upon addition to the per-
meabilized cell assay.
CRT contains a hydrophobic signal sequence to specify
targeting to the ER. Nonetheless, digitonin permeabiliza-
tion of HeLa cells releases approximately one third of to-
tal CRT under conditions where the ER remains intact, as
assessed by immunoblotting for the lumenal proteins
Grp94, ERp72, and PDI. Furthermore, the subcellular
fractionation of HeLa cells clearly demonstrates the pres-
ence of a significant cytosolic pool of CRT. Since genomic
analysis, Northern blotting, and EST sequencing have not
provided evidence for a CRT isoform that lacks a signal
sequence, the molecular mechanism for generating cytoso-
lic CRT is obscure. CRT could be produced posttransla-
tionally by retrotranslocation from the lumenal to cyto-
plasmic compartments (Johnson and van Waes, 1999).
Alternatively, cytosolic CRT could be translated on ribo-
somes that are not engaged with the ER. The synthesis of
signal sequence–containing proteins on free ribosomes is
known to occur in budding yeast (Matlack et al., 1998).
Recombinant CRT stimulates nuclear export of GR in
the permeabilized cell assay. In contrast, purified Crm1
does not stimulate nuclear export of GR (Holaska, J.M.,
and B.M. Paschal, unpublished observations), presumably
because Crm1 fails to bind to the export signal in GR. This
is consistent with our finding that nuclear export of the
GR in vivo proceeds on a pathway that is independent of
Crm1, based on its insensitivity to LMB. Significant evi-
dence that CRT is, in fact, required for nuclear export of
GR was obtained by using cells lacking CRT. We showed
that GR export is deficient in crt2/2 cells, and that GR ex-
port can be restored by reintroduction of CRT into the
cells. We have also found that GR export can be restored
by expression of CRT that lacks its NH2-terminal signal
sequence (Holaska, J.M., and B.M. Paschal, unpublished
observations). This indicates that the cytosolic, nonER
form of CRT is sufficient to promote nuclear export of GR
in vivo. These observations, taken together, are consistent
with our proposal that CRT defines a Crm1-independent
mechanism that is used for nuclear export of nuclear re-
ceptors such as GR.
CRT appears to mediate nuclear export of GR through
a direct protein–protein interaction. In vitro, CRT can
bind to the sequence KGFFKR, which is situated between
the two zinc fingers in the DNA recognition helix of GR
(Burns et al., 1994). Notably, it has been shown using puri-
fied components that CRT can prevent binding of GR to
its glucocorticoid response element (GRE) in mobility
shift assays, and overexpression of CRT inhibits GR-
dependent transcriptional activation from a GRE-depen-
dent reporter gene in vivo (Burns et al., 1994). These results
showing that CRT can antagonize GR function together
with our finding that CRT mediates nuclear export of GR
led us to hypothesize that the DBD within GR functions
as the NES. Three results indicate this hypothesis is cor-
rect. First, the DBD of GR can function as an NES in the
context of a GFP fusion protein. Second, a peptide con-
taining the DNA recognition helix from the DBD is suffi-
cient to specify nuclear export after microinjection into
the nucleus. Third, the DNA recognition helix peptide
blocks CRT-dependent export of GR in permeabilized
cells. Results showing that CRT also inhibits the activities
of the androgen and vitamin D receptors (Dedhar et al.,
1994; Wheeler et al., 1995), together with the sequence
similarity of the DBD in these and other hormone recep-
tors, indicates that our study has revealed both the recep-
tor and the signal for a major export pathway
The data we have presented, together with previous
studies linking nuclear receptors and CRT, suggest a sim-
ple two-step model for regulating the function of these
transcriptional activators. The first step involves a direct
interaction between CRT and the DBD of nuclear recep-
tors, an event that is sufficient to block receptor associa-
tion with DNA in vitro. The second step involves nuclear
export of the nuclear receptor/CRT/RanGTP complex to
the cytoplasm, an event that would terminate transcrip-
tional activation until reimport occurs. The balance of
ligand-induced import and CRT-dependent export pro-
vides the cell with a nuclear transport–based mechanism
that may play an important role in regulating the activity
of a broad spectrum of nuclear receptors.
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